China SXT Pharma (NASDAQ: SXTC) to jump 2,500% - a purely technical move

China SXT Pharmaceutical (NASDAQ: SXTC) stock should jump 2,500% at the open. This 25x rise in SXTC stock is not to be taken as proof that they’ve suddenly started to make money or anything. This is a purely technical change to do with keeping the Nasdaq quote alive and avoiding relegation down to the OTC market.

We looked at China SXT before: “Now, what we think is happening here is that there’s some speculation in China SXT Pharma. We have no idea why and we’re not sure anyone else does either. There is no news on it - just one of those things which happens in thin markets with microcaps. We’re willing to be informed differently on it but that’s what we think at our pixel time. This is then triggering people to make the mistake of trading in China Pharma pushing that microcap up 56%. There is no news on the China (not SXT) Pharma either. So we really do think that this is nominative indeterminism. And the speculation in CP is just a derivation of the speculation in C SXT P.  This really does happen - people trade in the wrong stock just because names appear to be similar. Make sure that’s not you.”

This is still good advice - don’t get confused between the two very similarly named companies, China Pharmaceutical and China SXT Pharmaceutical. Only one of them is going to move by that 2,500% today.

China SXT Pharmaceutical stock price from Google Finance

The specific problem here is that China SXT requires ongling access to capital. That means staying on Nasdaq. But you can’t stay on Nasdaq as a penny stock. There’s that $1 minimum bid price to deal with. So, something must be done and that something is to declare 25 old shares to be one new one - a one for 25 reverse stock split: “China SXT Pharmaceuticals, Inc. (SXTC) will effect a one-for-twenty five (1-25) reverse split of its Ordinary Shares. The reverse stock split will become effective on Thursday, October 5, 2023.”

This doesn’t change the value of the company overall, not directly at least, just the number of shares that make it up. Therefore the stock price reacts mechanically, rising 2,500%, or 25x. That solves the penny stock problem. That’s also the only problem solved here, the retention of that Nasdaq quote and listing - it doesn’t sort out the company’s business line in the slightest. Nor, obviously, does it sort out any possible confusion with China Pharmaceutical.